Related Experiment Video
Updated: Apr 15, 2026
10:17
Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience
Published on: November 15, 2024
1.9K
Evaluation of a shared pharmacogenomics curriculum for pharmacy students
Kelly C Lee1, Karen Suchanek Hudmon, Joseph D Ma
1University of California, San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences, 9500 Gilman Drive, Pharmaceutical Sciences Building, La Jolla, CA 92093-0719, USA.
Pharmacogenomics
|April 1, 2015
Summary
Pharmacy students demonstrated significant improvements in pharmacogenomics knowledge and self-efficacy after a shared curriculum. This educational approach effectively disseminated pharmacogenomics across multiple pharmacy schools.
Area of Science:
- Pharmacogenomics Education
- Pharmacy Curriculum Development
- Health Professions Education
Background:
- Pharmacogenomics integration into pharmacy curricula is crucial for modern patient care.
- A standardized curriculum facilitates broad dissemination of pharmacogenomics knowledge.
- Existing educational programs require evaluation for effectiveness and scalability.
Purpose of the Study:
- To assess the impact of a shared pharmacogenomics curriculum on pharmacy students' abilities, self-efficacy, and attitudes.
- To evaluate student perceptions of the Pharmacogenomics Education Program.
- To determine the effectiveness of a train-the-trainer model for curriculum dissemination.
Main Methods:
- A national study involving 43 Doctor of Pharmacy schools.
- Pre- and post-training surveys administered to over 2500 pharmacy students.
- Train-the-trainer programs were conducted for pharmacy faculty.
Main Results:
- Significant increases in students' ability to educate patients on pharmacogenomics (17% to 63%) and pharmacogenomic testing (11% to 60%).
- Substantial gains in self-efficacy for identifying appropriate pharmacogenomic testing applications (20% to 75%).
- Over 90% of students believed the curriculum would benefit peers at other institutions.
Conclusions:
- A shared pharmacogenomics curriculum is an effective strategy for widespread educational dissemination.
- The train-the-trainer model successfully facilitated the implementation of the curriculum.
- The study supports the adoption of standardized pharmacogenomics education in pharmacy programs.
More Related Videos
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
194
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
194
01:29Pharmacogenomics: Identification of New Drug Targets
94
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
94
01:27Pharmacogenetics of Drug Metabolism: Overview
157
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
157
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
129
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
129
01:27Principles of Pharmacogenetics: Types of Genetic Variants
119
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
119
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
239
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
239